Staff with the U.S. Food and Drug Administration (FDA) on Friday flagged the risk of heart inflammation following the administration of the Novavax COVID-19 vaccine, although they concluded the shot reduces the risk of mild-to-severe COVID-19. In the company’s nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis,…
Novavax’s 22 Percent Post-Earnings Plunge: 5 Factors That Took Toll
May 11, 2022
admin
Business & EconomyBusinesses in COVID-19CCP VirusCompaniesEarningeconomyNovavaxSharesVaccines & SafetyWorld
0 Comment
Novavax, Inc. shares slumped 22.27 percent after-hours on Monday, reacting to its quarterly financial report. What would have been a trophy quarter to flaunt, given COVID-19 revenue only just began to trickle in, turned out to be a big disappointment. Here’re five reasons why the COVID-19 vaccine maker’s report triggered a negative reaction: 1. Vaccine…
Novavax COVID-19 Vaccine May Be Issued Emergency Use Authorization in June: FDA
The U.S. Food and Drug Administration (FDA) announced Friday that it will have its advisory panel meet to discuss Novavax’s request for emergency use authorization (EUA) of its COVID-19 vaccine in June. “On June 7, FDA intends to convene VRBPAC [Vaccines and Related Biological Products Advisory Committee] to discuss an EUA request for a COVID-19…
Novavax Asks EU Regulator to Clear COVID Vaccine for Teens
LONDON—The pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent. In a statement on Thursday, Novavax said its request is based on data from research in more than 2,200 adolescents aged…
Novavax’s COVID Vaccine Rollout in EU Off to a Slow Start: Data
BRUSSELS—Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union’s main countries in the early rollout, so far undermining hopes that it could convince vaccine sceptics to get a shot. Over 85% of adults in the 27-country EU bloc have received at least one dose and nearly…
Chart Wars: Between Moderna and Novavax, Which COVID Stock Will Soar Higher?
March 10, 2022
admin
AMERICABusiness & EconomyBusinesses in COVID-19CCP VirusCompanieseconomyMarketsModernaNovavaxstockstocksVaccineVaccines & SafetyWorld
0 Comment
Moderna, Inc. and Novavax, Inc. were trading up over 10 percent and 8 percent, respectively, at one point on Wednesday, boosted by the S&P 500’s almost 2.6 percent intraday gain. The pharmaceutical stocks have been heavily beaten down over the past many months, with Moderna declining over 70 percent from its Aug. 10, 2021 all-time high…
Novavax Approved as Booster Alternative for Australians 18 and Over
March 2, 2022
admin
AstrazenecaAstraZeneca VaccineAustraliaAustralian Technical Advisory Group on ImmunisationCCP Viruscovid-19 booster shotsGreg Huntjohn skerrittNovavaxTherapeutic Goods AdministrationVaccines & SafetyWorld
0 Comment
The Novavax COVID-19 protein vaccine has been approved by the ATAGI as a booster alternative to mRNA vaccines for Australians aged 18 and over. The ATAGI stated (pdf) that the Novavax COVID-19 vaccine currently has “limited evidence” on its safety and immunogenicity as a booster, but is acceptable as a third shot if “no other COVID-19…
Australia Approves Moderna Vaccine For 6 to 11s
February 23, 2022
admin
AustraliaCCP VirusCOVAX-19Greg Huntjohn skerrittModernaModerna COVID-19 vaccineNovavaxVaccines & SafetyWorld
0 Comment
The Moderna COVID-19 vaccine has now been approved as the primary course for children aged 6 to 11 in Australia. Speaking at the press conference on Feb. 23, Health Minister Greg Hunt said Moderna gives “more choice and flexibility” for parents along with the Pfizer vaccine which is approved for children aged 5 and older….
Novavax Vaccine Approved for Use in Singapore
Singapore has approved the use of the Nuvaxovid vaccine by Novavax in its National Vaccination Programme for individuals aged 18 years and above for both the primary and booster vaccination shot.
Novavax COVID 19 Vaccine Gets Approval for Use in Canada
The Novavax COVID-19 vaccine has been approved for use in Canada. The vaccine, which is protein-based, is the first of its kind to get approval in the country. Experts say a non-mRNA vaccine could win over some vaccine-hesitant people who have still not received a dose of a COVID-19 vaccine. The U.S. company Novavax Inc….
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`